Gnoth, K.; Geissler, S.; Feldhaus, J.; Taudte, N.; Ilse, V.; Zürner, S.; Greiser, S.; Braumann, U.-D.; Rahfeld, J.-U.; Cynis, H.;
et al. Evidence for Enhanced Efficacy of Passive Immunotherapy against Beta-Amyloid in CD33-Negative 5xFAD Mice. Biomolecules 2022, 12, 399.
https://doi.org/10.3390/biom12030399
AMA Style
Gnoth K, Geissler S, Feldhaus J, Taudte N, Ilse V, Zürner S, Greiser S, Braumann U-D, Rahfeld J-U, Cynis H,
et al. Evidence for Enhanced Efficacy of Passive Immunotherapy against Beta-Amyloid in CD33-Negative 5xFAD Mice. Biomolecules. 2022; 12(3):399.
https://doi.org/10.3390/biom12030399
Chicago/Turabian Style
Gnoth, Kathrin, Stefanie Geissler, Julia Feldhaus, Nadine Taudte, Victoria Ilse, Sebastian Zürner, Sebastian Greiser, Ulf-Dietrich Braumann, Jens-Ulrich Rahfeld, Holger Cynis,
and et al. 2022. "Evidence for Enhanced Efficacy of Passive Immunotherapy against Beta-Amyloid in CD33-Negative 5xFAD Mice" Biomolecules 12, no. 3: 399.
https://doi.org/10.3390/biom12030399
APA Style
Gnoth, K., Geissler, S., Feldhaus, J., Taudte, N., Ilse, V., Zürner, S., Greiser, S., Braumann, U.-D., Rahfeld, J.-U., Cynis, H., & Schilling, S.
(2022). Evidence for Enhanced Efficacy of Passive Immunotherapy against Beta-Amyloid in CD33-Negative 5xFAD Mice. Biomolecules, 12(3), 399.
https://doi.org/10.3390/biom12030399